Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Alta Global Group | MMA | Aug 30, 2024 | 3.06 | -4.30 |
Altair Engineering A | ALTR | Aug 30, 2024 | 90.36 | +0.98 |
Altamira Therapeutics | CYTO | Aug 30, 2024 | 0.89 | -2.49 |
AltC Acquisition A | ALCC | Aug 30, 2024 | 18.23 | 0.00 |
AltEnergy Acquisition A | AEAE | Aug 30, 2024 | 11.11 | -7.34 |
AltEnergy Acquisition Unit | AEAEU | Aug 30, 2024 | 11.15 | 0.00 |
Alterity Therapeutics ADR | ATHE | Aug 30, 2024 | 1.49 | -1.32 |
Alternus Clean Energy A | ALCE | Aug 30, 2024 | 0.23 | -5.09 |
Alti Global A | ALTI | Aug 30, 2024 | 4.02 | 0.00 |
Altice USA A | ATUS | Aug 30, 2024 | 1.84 | -1.08 |
Altimmune | ALT | Aug 30, 2024 | 6.70 | +1.36 |
Altisource Asset Management | AAMC | Aug 30, 2024 | 1.25 | -1.65 |
Altisource Portfolio Solutions | ASPS | Aug 30, 2024 | 1.16 | +0.87 |
Alto Ingredients | ALTO | Aug 30, 2024 | 1.38 | 0.00 |
Alto Neuroscience | ANRO | Aug 30, 2024 | 12.81 | +2.48 |
Altria Group | MO | Aug 30, 2024 | 53.77 | +0.77 |
Altus Power A | AMPS | Aug 30, 2024 | 3.12 | 0.00 |
Alumis | ALMS | Aug 30, 2024 | 12.70 | 0.00 |
Alvotech | ALVO | Aug 30, 2024 | 11.68 | +0.26 |
ALX Oncology | ALXO | Aug 30, 2024 | 2.32 | +0.87 |
Alzamend Neuro | ALZN | Aug 30, 2024 | 2.35 | +2.62 |
Amalgamated Financial | AMAL | Aug 30, 2024 | 32.99 | +0.52 |
Amarin ADR | AMRN | Aug 30, 2024 | 0.63 | +3.18 |
Amazon.com | AMZN | Aug 30, 2024 | 178.50 | +3.71 |
Ambac Financial Group | AMBC | Aug 30, 2024 | 11.70 | +0.17 |
Ambarella | AMBA | Aug 30, 2024 | 59.70 | +0.71 |
Ambev ADR | ABEV | Aug 30, 2024 | 2.27 | -0.44 |
Ambipar Emergency Response | AMBI | Aug 30, 2024 | 4.22 | +3.18 |
Ambow Education A ADR | AMBO | Aug 30, 2024 | 1.30 | +4.00 |
AMC Entertainment A | AMC | Aug 30, 2024 | 4.82 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.